Topic: GSK
65 results were found.
ABL Bio lands $2.8 licensing agreement with GSK - April 11, 2025
Pennsylvania: GSK will create at least 200 new, high-paying jobs in Lancaster County - October 25, 2024
CureVac sells COVID-19, flu vaccines to GSK amid restructuring - July 5, 2024
GSK gonorrhoea treatment achieves efficacy endpoint in latest trial - February 26, 2024
GSK to acquire Aiolos Bio for up to $1.4 billion - February 2, 2024
GSK Q4 profit down to 379 million pounds - January 31, 2024
GSK seeks regulatory approval to extend RSV vaccination to at-risk adults aged 50-59 - January 31, 2024
GSK enters agreement to acquire Aiolos Bio for $1.4 billion - January 9, 2024
GSK endometrial cancer treatment gets Europe authorisation - December 11, 2023
GSK to acquire exclusive rights to Janssen’s hepatitis B therapy in $1bn deal - November 3, 2023
GSK’s Arexvy RSV vaccine approved in Japan for adults aged 60 and above - September 27, 2023
GSK sues Pfizer over patent infingements for RSV vaccine - August 3, 2023
GSK to sell $1 billion Haleon stake - May 12, 2023
FDA approves first RSV vaccine from GSK - May 4, 2023
GSK Q1 profit 1.49 billion pounds - April 26, 2023
UK GSK workers to strike throughout May in pay dispute - April 21, 2023
GSK to buy Canada's Bellus Health for $2 billion - April 18, 2023
Strike action resumes at GSK pharmaceutical plant in Irvine, Scotland - February 6, 2023
GSK Q4 profit climbs - February 1, 2023
GSK to restrict use of ovarian cancer therapy Zejula to certain patients - November 11, 2022
GSK Q3 profit decreased - November 2, 2022
GSK Q2 earnings per share £0.347 - July 28, 2022
GSK spins off consumer health business Haleon - July 18, 2022
GSK's measles prevention vaccine gets U.S. approval - June 6, 2022
GSK to buy Affinivax in $3.3 billion deal - May 31, 2022
Germany agrees deal with CureVac, GSK for mRNA vaccines until 2029 - April 12, 2022
GSK, Sanofi COVID jab booster shows strong immune response - December 15, 2021
GSK Vir drug works against all Omicron variants - December 7, 2021
Britain approves GSK-Vir antibody-based COVID-19 treatment - December 2, 2021
GSK to support manufacture of Novavax COVID-19 vaccine - April 3, 2021
GSK and CureVac to develop next generation mRNA COVID-19 vaccines - February 3, 2021
Russia's Sputnik V developers ready to share technology with Sanofi and GSK - December 11, 2020
Sanofi, GSK announce delay in coronavirus vaccine until end of 2021 - December 11, 2020
Sanofi and GSK sign agreements with Canada to supply up to 72 million doses of coronavirus vaccine - September 23, 2020
GSK and Sanofi in talks to supply 300m vaccine doses to EU - August 3, 2020
Sanofi and GSK agree with UK government to supply more than 50 million doses of coronaviris vaccine - July 29, 2020
GSK and Novartis allegedly misled consumers with Voltaren Osteo Gel claims - May 21, 2019
UK drops corruption charges against GSK and Rolls-Royce in foreign countries - February 25, 2019
GSK reaches agreement to acquire TESARO for $5.1 billion - December 5, 2018
Unilever agrees £3.1 billion Horlicks deal with GSK - December 3, 2018
GSK turns to profit in Q2 - July 25, 2018
GSK to buy Novartis stake in JV for $13 billion - March 27, 2018
GSK steps back from $20 billion race for Pfizer assets - March 23, 2018
GSK cuts back in Africa after disappointing sales - January 19, 2018
Australia takes GSK, Novartis to court over misleading claims - December 6, 2017
Avara Pharmaceutical Services buys consumer healthcare facility from GSK - September 25, 2017
GSK appoints Laurie Glimcher as director - July 24, 2017
GSK president, global pharma Abbas Hussain to leave - January 20, 2017
GSK Q3 sales increased 8% to £7.5 billion - October 26, 2016
Brian McNamara named as CEO of GSK consumer healthcare - September 30, 2016
GSK raises £477m from selling final Aspen shares - September 29, 2016
GSK links with Alphabet on new bioelectronics company - August 1, 2016
GSK director Moncef Slaoui to retire - June 15, 2016
GSK appoints Vivienne Cox as director - May 30, 2016
GSK first-quarter sales up 11%, profit falls - April 27, 2016
GSK receives approvals for stem cell gene therapy - April 4, 2016
GSK, AstraZeneca, Johnson & Johnson join forces with UK universities - January 26, 2016
GSK’s ViiV Healthcare to acquire Bristol-Myers Squibb’s R&D HIV assets - December 18, 2015
Perrigo completes acquisition of OTC brands from GSK - August 29, 2015
Novartis is buying ofatumumab from GSK for $1 billion - August 21, 2015
Perrigo to buy assets from GSK Consumer Healthcare - June 3, 2015
GSK: Simon Dingemans new CFO - September 9, 2010
Patrick Vallance appointed to GSK executive leadership team - May 13, 2010
GSK appointed Philippe Fauchet as President of GSK Japan - February 15, 2010
Valeant Pharmaceuticals appoints Steve Stefano of GSK to the Board of Directors - March 31, 2009